Skip To Main Content
Spigel DR on Muck Rack

Spigel DR

As seen in: Nature, European Respiratory Review
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Spigel

Contact Spigel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors

|
By Spigel DR, Falchook GS, Imedio ER, Mugundu GM
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (356) Issue with article?

Update on recent key publications in lung oncology: picking up speed

|
By Spigel DR, O'Byrne K, Stefan Andreas, Edelman MJ
| European Respiratory Review Verified
Achim Rittmeyer, Annett Schiwitza, Lejla Sahovic, Bastian Eul, Stefan Andreas European Respiratory Review 2021 30: 200300; DOI: 10.1183/16000617.0300-2020 Abstract Introduction As incidence rates for lung cancer are still very high and lung cancer remains the most deadly cancer since the turn of the millennium, efforts have been made to find new approaches in cancer research.
Open in Who Shared Issue with article?

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

|
By Leiby MA, Paris PL, Paz-Ares L, Spigel DR
| Nature Verified
PD-L1 expression in tumour tissues is widely used to select patients to receive anti-PD-1/PD-L1 antibodies, but data are lacking on the correlation of plasma PD-L1 levels with the effect of treatments. To investigate the association between PD-L1 mRNA in plasma-derived exosomes and response to nivolumab and pembrolizumab in patients with melanoma (n=18) and NSCLC (n=8), blood was obtained at time point 0 and after 2 months. Exosomal PD-L1 mRNA was measured by digital droplet PCR.
Open in Who Shared Issue with article?
See all 4 articles